Literature DB >> 27189829

Binding Affinity and Interaction of LL-37 with HLA-C*06:02 in Psoriasis.

Tomotaka Mabuchi1, Noriaki Hirayama2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27189829     DOI： 10.1016/j.jid.2016.04.033

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  10 in total

Review 1.  Immune responses and therapeutic options in psoriasis.

Authors:  Inna S Afonina; Elien Van Nuffel; Rudi Beyaert
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

2.  HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study.

Authors:  Marina Talamonti; Marco Galluzzo; Arianna Zangrilli; Marina Papoutsaki; Colin Gerard Egan; Mauro Bavetta; Sara Tambone; Maria Concetta Fargnoli; Luca Bianchi
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

3.  Genetics of psoriasis: a basis for precision medicine.

Authors:  Delin Ran; Minglong Cai; Xuejun Zhang
Journal:  Precis Clin Med       Date:  2019-06-24

Review 4.  The Genetic Basis of Psoriasis.

Authors:  Francesca Capon
Journal:  Int J Mol Sci       Date:  2017-11-25       Impact factor: 5.923

Review 5.  Significance of LL-37 on Immunomodulation and Disease Outcome.

Authors:  Binbin Yang; David Good; Tamim Mosaiab; Wei Liu; Guoying Ni; Jasmine Kaur; Xiaosong Liu; Calvin Jessop; Lu Yang; Rushdi Fadhil; Zhengjun Yi; Ming Q Wei
Journal:  Biomed Res Int       Date:  2020-05-16       Impact factor: 3.411

Review 6.  Psoriasis and Antimicrobial Peptides.

Authors:  Toshiya Takahashi; Kenshi Yamasaki
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

Review 7.  HLA-Cw1 and Psoriasis.

Authors:  Yi-Wei Huang; Tsen-Fang Tsai
Journal:  Am J Clin Dermatol       Date:  2021-01-18       Impact factor: 7.403

Review 8.  Update on the etiopathogenesis of psoriasis (Review).

Authors:  Daciana Elena Branisteanu; Catalina Cojocaru; Roxana Diaconu; Elena Andrese Porumb; Anisia Iuliana Alexa; Alin Codrut Nicolescu; Ilarie Brihan; Camelia Margareta Bogdanici; George Branisteanu; Andreea Dimitriu; Mihail Zemba; Nicoleta Anton; Mihaela Paula Toader; Adrian Grechin; Daniel Constantin Branisteanu
Journal:  Exp Ther Med       Date:  2022-01-05       Impact factor: 2.447

Review 9.  S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases.

Authors:  Katarzyna Kurpet; Grażyna Chwatko
Journal:  Molecules       Date:  2022-10-06       Impact factor: 4.927

Review 10.  New Treatment Addressing the Pathogenesis of Psoriasis.

Authors:  Michio Tokuyama; Tomotaka Mabuchi
Journal:  Int J Mol Sci       Date:  2020-10-11       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.